Morris Birnbaum to Give Inaugural Joseph Larner Memorial Lecture in Pharmacology

Save the date! Our first annual Joseph Larner Memorial Lecture in Pharmacology will be held on Wednesday, November 18, 2015. We are pleased to announce that Morris J. Birnbaum, M.D., Ph.D. will be presenting the inaugural lecture. Dr. Birnbaum is the Senior Vice President and Chief Scientific Officer of the Cardiovascular and Metabolic Disease (CVMED) Research Unit at Pfizer, which focuses on developing therapies to treat, slow or prevent disease progression and improve the quality of life of patients with obesity, type 2 diabetes (T2D), cardiovascular (CV), and kidney diseases. Dr. Birnbaum is a leading researcher in the signals that regulate and integrate metabolic pathways in liver, muscle, and adipose tissue, and how they are disrupted in insulin resistant states. Learn more about Dr. Birnbaum here.

Joseph Larner

Joseph Larner, M.D., Ph.D.

More details will be forthcoming soon about the lecture (time, location, etc.) – but for now, please hold the date for this exciting seminar!

The Joseph Larner Memorial Lectureship was recently established to honor Dr. Larner’s memory and to highlight exciting new advances in an area that held great interest for him: the pervasive role of metabolism/cell signaling in human disease.